, Tracking Stock Market Picks
Enter Symbol:
Auxilium Pharmaceuticals, Inc. (AUXL) [hlAlert]

down 11.35 %

Auxilium Pharmaceuticals, Inc. (AUXL) rated Sell with price target $13 by Brean Murray

Posted on: Wednesday,  Sep 7, 2011  11:25 AM ET by Brean Murray

Brean Murray rated Sell Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on 09/07/2011. Previously Brean Murray rated Sell Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on
09/30/2008., when the stock price was $32.33. Since then, Auxilium Pharmaceuticals, Inc. has gained 12.81% as of 01/29/2015's recent price of $36.47.
If you would have followed the previous Brean Murray's recommendation on AUXL, you would have lost 11.35% of your investment in 2312 days.

Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions, as well as other products for urology and sexual health, including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/7/2011 11:25 AM Sell
16.45 13.00
as of 12/30/2011
1 Week down  -2.20 %
1 Month down  -14.34 %
3 Months down  -32.95 %
1 YTD up  5.54 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/6/2009 4:25 PM Sell
29.72 15.00
9/30/2008 8:25 AM Sell
32.33 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy